Company Filing History:
1 out of 517 
1 out of 4,456 
1 out of 2,886 
Years Active: 2025
Title: Edward Christian Rosfjord: Innovator in Antibody Drug Conjugates
Introduction
Edward Christian Rosfjord is a notable inventor based in Oakland, NJ (US). He has made significant contributions to the field of targeted therapy, particularly through his work on CDCP1 antibodies and antibody drug conjugates. His innovative approach has the potential to impact cancer treatment and other medical applications.
Latest Patents
Edward Christian Rosfjord holds 1 patent related to his work on CUB domain-containing protein 1 (CDCP1)-targeted therapy. This patent provides materials and methods that could enhance therapeutic strategies in treating various diseases.
Career Highlights
Throughout his career, Rosfjord has worked with prestigious organizations, including Beth Israel Deaconess Medical Center, Inc. and Pfizer Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Lewis C. Cantley and Stephen P. Soltoff. Their collaboration has likely fostered an environment of innovation and excellence in research.
Conclusion
Edward Christian Rosfjord's work in the development of CDCP1-targeted therapies exemplifies the impact of innovative thinking in medicine. His contributions continue to pave the way for advancements in targeted therapies and improve patient outcomes.